This industry briefing gives an overview of the global commercial landscape in regenerative medicine and relative strengths in Ontario. After 30 years of research, many regenerative medicine technologies are in development and approaching commercialization. Clinical programs are underway worldwide and patients can look forward to numerous innovative solutions to pressing global health issues in the years ahead. A swelling wave of scientific discovery funded by major government initiatives has helped create unprecedented momentum in this exciting field. Canadian medical researchers have been at the vanguard of regenerative medicine since the 1960s. Given the rapid maturation of the regenerative medicine industry, the time is ripe to transform Canadian scientific leadership into commercial outcomes.
01 Jan 2009